Exact Sciences
EXAS
#1148
Rank
C$28.25 B
Marketcap
C$148.03
Share price
0.00%
Change (1 day)
96.04%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): C-$2.13

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.51. In 2022 the company made an earnings per share (EPS) of C-$5.00 a decrease over its 2021 EPS that were of C-$4.88.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$2.13-57.26%
2022C-$5.002.31%
2021C-$4.88-37.09%
2020C-$7.76674.65%
2019C-$1.00-50.69%
2018C-$2.0344%
2017C-$1.41-39.39%
2016C-$2.33-2.94%
2015C-$2.4037.1%
2014C-$1.7579.71%
2013C-$0.97-21.59%
2012C-$1.2462.96%
2011C-$0.7692.86%
2010C-$0.40-3.45%
2009C-$0.41-19.44%
2008C-$0.51-18.18%
2007C-$0.62-10.2%
2006C-$0.69-10.91%
2005C-$0.78-24.66%
2004C-$1.03-51.33%
2003C-$2.12-7.41%
2002C-$2.2911.72%
2001C-$2.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.69-135.77%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
C$2.03-127.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.48-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$1.68-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$71.82 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA